Extraneuronal Manifestations of Alzheimer's Disease

Journal of the American Geriatrics Society

Volumn 41, Issue 3, 1993, Pages 268-276

  Scott, Robert B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA 1 ANTICHYMOTRYPSIN; AMINE OXIDASE (FLAVIN CONTAINING); CALCIUM ION; CATALASE; CHOLINE; CHOLINESTERASE; CYCLIC AMP; CYTOCHROME C OXIDASE; DNA; FATTY ACID; HEXOKINASE; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TRANSKETOLASE;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHOLINERGIC SYSTEM; DNA SYNTHESIS; DRUG BINDING SITE; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE MEMBRANE; MEMBRANE BIOLOGY; MEMBRANE FLUIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN FIBROBLAST; THROMBOCYTE MEMBRANE; TISSUE DISTRIBUTION;

EID: 0027502252     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1993.tb06704.x     Document Type: Article

References (98)

1. Alzheimer's disease: A metabolic systems degeneration?
2. Systemic manifestations of Alzheimer's disease
3. Cerebrospinal fluid markers of Alzheimer's disease
4. Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease
5. Elevation of erythrocyte countertransport rates in Alzheimer's dementia
6. X‐ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease
7. Hippocampal membrane alterations in Alzheimer's disease
8. Biophysical alterations in cell membranes associated with psychotherapeutic drug exposure, psychopathology, and aging
9. Platelet and erythrocyte membrane changes in Alzheimer's disease
10. Red blood cell abnormalities in Alzheimer disease
11. Abnormal erythrocyte choline and influx in Alzheimer's disease
12. Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease
13. Red blood cell choline. I: Choline in Alzheimer's disease
14. Differences in red blood cell choline and lipid‐bound choline between patients with Alzheimer disease and control subjects
15. Blood activity of Cu/Zu superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: A case‐control study
16. Reduced activities of thiamine‐dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease
17. Tin and fatty acids in dementia
18. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease
19. Philothermal response of polymorphonuclear leukocytes in dementia of the Alzheimer type
20. Magnesium and potassium status in elderly subjects with and without dementia of the Alzheimer type
21. Altered membrane anisotropy gradients of plasma membranes of living peripheral blood leukocytes in aging and Alzheimer's disease
22. Altered post‐receptorial signal transduction mechanism under various stimulation in polymorphonuclear granulocytes of Alzheimer's disease
23. DNA repair deficiency for alkylating damage in cells from Alzheimer disease patients
24. Decreased DNA repair capacity in familial, but not in sporadic Alzheimer's disease
25. Parkinson's disease and Alzheimer's disease: Hypersensitivity to X‐rays in cultured cell lines
26. Heterogeneity in Alzheimer's disease: Evidence from cellular radiosensitivity and complementation of this phenotype
27. Normal inhibition of DNA synthesis following gamma‐irradiation of radiosensitive cell lines from patients with Down's syndrome and Alzheimer's disease
28. Chromosomal radiosensitivity of lymphocytes from Alzheimer's disease patients
29. Chromosomal abnormality in dementia of the Alzheimer type
30. Immunological indices in presenile Alzheimer's disease
31. Radiosensitivity of lymphocytes from patients with Alzheimer's disease
32. Immunological studies in senile dementia of the Alzheimer type: Evidence for enhanced suppressor cell activity
33. Immunologic dysfunction: Simultaneous study of Alzheimer's and older Down's patients
34. Decreased natural killer cell activity in Alzheimer's disease [Abstract]
35. Macrophage and polymorphonuclear leukocyte function in patients with Alzheimer disease
36. Study of spindle microtubule reassembly in cells from Alzheimer and Down syndrome patients following exposure to colcemid
37. Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease
38. Diminished mitogen‐induced calcium uptake by lymphocytes from Alzheimer patients
39. Increased cytosolic free calcium in lymphocytes of Alzheimer patients
40. Abnormal and deficient processing of β‐amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells
41. Immunological dysfunction in Alzheimer's disease
42. Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients
43. Cholinergic muscarinic binding by human lymphocytes: Changes with aging, antagonist treatment, and senile dementia of the Alzheimer type
44. Exrraneuronal cholinergic markers in Alzheimer's and Parkinson's disease
45. An analysis of lymphocyte 3H‐N‐methylscopolamine binding in neurological patients
46. Proliferation of internal membranes in platelets from patients with Alzheimer's disease
47. Family study of platelet membrane fluidity in Alzheimer's disease
48. Proliferation of internal membranes in platelets from patients with Alzheimer's disease
49. Platelet membrane properties in Alzheimer and multi‐infarct dementias
50. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients
51. Platelet membrane fluidity in Alzheimer's disease and multi‐infarct dementia: A spin label study
52. Endoplasmic reticulum abnormality in Alzheimer's disease: Selective alteration in platelet NADH‐cytochrome C reductase activity
53. Cytochrome oxidase deficiency in Alzheimer's disease
54. Monoamine oxidase, brain ageing and degenerative disease
55. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
56. Increased platelet 3H‐imipramine binding and monoamine oxidase B activity in Alzheimer's disease
57. Vitamin B12‐induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia
58. Platelet benzodiazepine binding in Alzheimer's disease
59. Alzheimer's dementia and binding to alpha‐2—adrenoreceptors in platelets
60. Serum immunoglobulins and cognitive status in the elderly: I. A population study
61. Studies of the specificity of antibrain antibodies in Alzheimer's disease
62. Antibodies to cholinergic neurons in Alzheimer's disease
63. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons
64. Antibodies in serum of patients with Alzheimer's disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex
65. Plasma and erythrocyte acetylcholinesterase in senile dementia of the Alzheimer type
66. Possible participation of calcium‐regulating factors in senile dementia in elderly female subjects
67. Serum concentration of alpha 1‐antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type
68. 1‐antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
69. Inhibition of normal polymorphonuclear leukocyte philothermal response by serum from dementia of the Alzheimer‐type patients
70. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
71. Hair aluminum in normal aged and senile dementia of Alzheimer type
72. Amyloid β‐protein deposition in tissues other than brain in Alzheimer's disease
73. Deficient repair of DNA lesions in Alzheimer's disease fibroblasts
74. Alzheimer disease fibroblasts are hypersensitive to the lethal effects of a DNA‐damaging chemical
75. Normal replicative lifespan of Alzheimer skin fibroblasts
76. Cellular ageing of Alzheimer's disease and Down syndrome cells in culture
77. Changes in adhesion efficiency and vimentin distribution of fibroblasts from familial Alzheimer's disease patients
78. Altered cell growth and induction of an interferon‐responsive gene in fibroblast lines derived from patients with familial Alzheimer's disease
79. Decreased adhesiveness of Alzheimer's disease fibroblasts: Is amyloid β‐protein precursor involved?
80. Deficiency of a cholinergic differentiating factor in fibroblasts of patients with Alzheimer's Disease
81. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors
82. Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors
83. Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors
84. Hormone responsiveness in cultured human skin fibroblasts from individuals with Down syndrome and Alzheimer's disease (Abstract)
85. Alzheimer disease fibroblasts accumulate more cyclic AMP in response to β‐adrenergic stimulation vs normal fibroblasts [Abstract]
86. Cultured cells as a screen for novel treatments of Alzheimer's disease
87. Expression of “Alzheimer antigens” in cultured skin fibroblasts
88. Alz‐50, a monoclonal antibody to Alzheimer's disease antigen, cross‐reacts with tau proteins from bovine and normal human brain
89. Occurrence of transketolase abnormalities in extracts of foreskin fibroblasts from patients with Alzheimer's disease
90. Enhanced proteolytic activities in cultured fibroblasts of Alzheimer patients are revealed by peculiar transketolase alterations
91. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease
92. Kinetic properties of the [Ca2++ Mg2+]‐ATPase in Alzheimer and normal fibroblasts at low free calcium
93. Reduced protein kinase C immuno‐reactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts
94. Superoxide dismutase activity in Alzheimer's disease: Possible mechanism for paired helical filament formation
95. Metals and the liver in Alzheimer's disease: An investigation of hepatic zinc, copper, cadmium, and metallothionein
96. Altered glucose metabolism in microvessels from patients with Alzheimer's disease
97. β‐amyloid and the pathogenesis of Alzheimer's disease
98. Researchers say Alzheimer's protein is ubiquitous